A citation-based method for searching scientific literature

Ayse Mavi, Tevfik F Cermik, Muammer Urhan, Halis Puskulcu, Sandip Basu, Jian Q Yu, Hongming Zhuang, Brian Czerniecki, Abass Alavi. J Nucl Med 2007
Times Cited: 63







List of co-cited articles
304 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
214
50

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
154
46

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
246
42

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
304
41

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
75
41

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
117
38

The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa. Breast Cancer 2007
71
38

Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, V De Sanctis, M Greco, M G Daidone,[...]. Eur J Nucl Med 1998
136
34

Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Naoki Ikenaga, Naoki Otomo, Atsushi Toyofuku, Yuji Ueda, Kiyokazu Toyoda, Tohru Hayashi, Kiyoshi Nishikawa, Masao Tanaka. Am Surg 2007
51
39

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
131
28

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, Michel Toubeau, Bruno Coudert, Laurent Arnould, Christophe Boichot, Alexandre Cochet, Pierre Fumoleau, François Brunotte. Eur J Nucl Med Mol Imaging 2007
130
23

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
413
23

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
354
22

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
57
24

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
122
20

Biological characterisation of breast cancer by means of PET.
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske. Eur J Nucl Med Mol Imaging 2004
66
17

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
251
15

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
188
14


Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.
M Oshida, K Uno, M Suzuki, T Nagashima, H Hashimoto, H Yagata, T Shishikura, K Imazeki, N Nakajima. Cancer 1998
178
14


Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
Rakesh Kumar, Vilert A Loving, Anil Chauhan, Hongming Zhuang, Schnall Mitchell, Abass Alavi. J Nucl Med 2005
162
12

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Tomoo Inoue, Kenji Yutani, Tetsuya Taguchi, Yasuhiro Tamaki, Eiichi Shiba, Shinzaburo Noguchi. J Cancer Res Clin Oncol 2004
74
12


FDG PET, PET/CT, and breast cancer imaging.
Eric L Rosen, William B Eubank, David A Mankoff. Radiographics 2007
141
11

High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
140
11

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
U Veronesi, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi,[...]. Ann Oncol 2007
113
11

Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Tevfik F Cermik, Ayse Mavi, Sandip Basu, Abass Alavi. Eur J Nucl Med Mol Imaging 2008
71
11

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
11

FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion.
Masatoyo Nakajo, Yoriko Kajiya, Tomoyo Kaneko, Youichi Kaneko, Takashi Takasaki, Atsushi Tani, Masako Ueno, Chihaya Koriyama, Masayuki Nakajo. Eur J Nucl Med Mol Imaging 2010
83
11

Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
147
11

18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim,[...]. Eur Radiol 2014
61
11


Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Selin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, Osama Mawlawi, Eric Rohren, Ana M Gonzalez Angulo, Shaheenah Dawood, Erika Resetkova, Huong T Le-Petross, Wei-Tse Yang. J Nucl Med 2009
65
9

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
88
9

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
J E Mortimer, F Dehdashti, B A Siegel, K Trinkaus, J A Katzenellenbogen, M J Welch. J Clin Oncol 2001
276
9

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
9

Increased FDG uptake in breast cancer is associated with prognostic factors.
Yasemin Sanli, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun. Ann Nucl Med 2012
47
12

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, Julie R Gralow, Robert B Livingston, Georgiana K Ellis, Philip H Petra, Lanell M Peterson, Erin K Schubert, Lisa K Dunnwald,[...]. J Clin Oncol 2006
256
7

Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
F Crippa, R Agresti, E Seregni, M Greco, C Pascali, A Bogni, C Chiesa, V De Sanctis, V Delledonne, B Salvadori,[...]. J Nucl Med 1998
126
7

Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
A A Zytoon, K Murakami, M R El-Kholy, E El-Shorbagy. Clin Radiol 2008
41
12

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.
Jörg Schwarz-Dose, Michael Untch, Reinhold Tiling, Stefanie Sassen, Sven Mahner, Steffen Kahlert, Nadia Harbeck, Annette Lebeau, Winfried Brenner, Markus Schwaiger,[...]. J Clin Oncol 2009
155
7

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
7

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Jean-Louis Alberini, Florence Lerebours, Myriam Wartski, Emmanuelle Fourme, Elise Le Stanc, E Gontier, O Madar, P Cherel, A P Pecking. Cancer 2009
72
7

The evolving role of PET/CT in breast cancer.
David Groheux, Sylvie Giacchetti, Domenico Rubello, Adil Al-Nahhas, Jean-Luc Moretti, Marc Espié, Elif Hindié. Nucl Med Commun 2010
11
45



Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
64
7

18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Bong-Il Song, Sang-Woo Lee, Shin Young Jeong, Yee Soo Chae, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee. J Nucl Med 2012
59
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.